When the comparison matters
These two defenses operate on different timescales but compound. A pill alone forces a hostile bidder to negotiate or risk dilution. A staggered board alone forces a hostile bidder through 2+ years of proxy contests. Combined, they create a near-absolute defense — explaining why hostile tender offers against staggered-board targets with available pill capacity are essentially extinct in modern U.S. M&A.
Modern dynamics
Institutional governance norms have largely killed staggered boards at large public companies (S&P 500 declassification rate now exceeds 90%). Poison pills survive as a quick-deploy defensive tool — most companies maintain the legal infrastructure to adopt one within hours of a credible threat.